Fiche publication
Date publication
mars 2019
Journal
Immunotherapy
Auteurs
Membres identifiés du Cancéropôle Est :
Dr AMARAL Teresa Maria
Tous les auteurs :
Amaral T, Tampouri I, Eigentler T, Keim U, Klumpp B, Heinrich V, Zips D, Paulsen F, Gepfner-Tuma I, Skardelly M, Tatagiba M, Tabatabai G, Garbe C, Forschner A
Lien Pubmed
Résumé
Melanoma brain metastases (MBM) are associated with a dismal prognosis. Few clinical trials evaluated the impact of immunotherapy (IT) and targeted therapy (TT) alone or in combination with surgery and radiotherapy in this population.
Mots clés
chemotherapy, dominant systemic therapy, immunotherapy, melanoma brain metastases, overall survival, radiosurgery, stereotactic radiation, surgery, targeted therapy, whole brain irradiation
Référence
Immunotherapy. 2019 03;11(4):297-309
